Calamos Advisors LLC

Holdings History for BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1

Investment type: Debt / NOTE 1.500%10/1

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
31 Dec 2020		-0.02%	$0	0	-2,848,000	-100%		Q4 2020
30 Sep 2020	0.02%	-0.05%	$2,848,000	2,848,000	-7,116,000	-71%	100.0%	Q3 2020
30 Jun 2020	0.1%	-0.22%	$13,114,000	9,964,000	-22,589,000	-69%	131.61%	Q2 2020
31 Mar 2020	0.27%	-0.14%	$34,509,000	32,553,000	-16,469,000	-34%	106.01%	Q1 2020
31 Dec 2019	0.29%	-0%	$53,288,000	49,022,000	-503,000	-1%	108.7%	Q4 2019
30 Sep 2019	0.3%	-0%	$51,243,000	49,525,000	-8,000	-0.02%	103.47%	Q3 2019
30 Jun 2019	0.33%	+0%	$55,756,000	49,533,000	+415,000	+0.84%	112.56%	Q2 2019
31 Mar 2019	0.37%	+0.01%	$55,878,000	49,118,000	+1,540,000	+3.2%	113.76%	Q1 2019
31 Dec 2018	0.38%	+0.01%	$53,058,000	47,578,000	+1,163,000	+2.5%	111.52%	Q4 2018
30 Sep 2018	0.37%	+0.01%	$55,748,000	46,415,000	+812,000	+1.8%	120.11%	Q3 2018
30 Jun 2018	0.38%	+0%	$54,089,000	45,603,000	+20,000	+0.04%	118.61%	Q2 2018
31 Mar 2018	0.37%	+0.15%	$50,500,000	45,583,000	+18,767,000	+70%	110.79%	Q1 2018
31 Dec 2017	0.24%	+0.07%	$31,856,000	26,816,000	+8,015,000	+43%	118.79%	Q4 2017
30 Sep 2017	0.18%	+0%	$22,627,000	18,801,000	+187,000	+1%	120.35%	Q3 2017
30 Jun 2017	0.18%	-0%	$22,265,000	18,614,000	-288,000	-1.5%	119.61%	Q2 2017
31 Mar 2017	0.18%	-0%	$22,414,000	18,902,000	-362,000	-1.9%	118.58%	Q1 2017
31 Dec 2016	0.18%	-0%	$22,710,000	19,264,000	-139,000	-0.72%	117.89%	Q4 2016
30 Sep 2016	0.17%	-0.04%	$24,221,000	19,403,000	-3,979,000	-17%	124.83%	Q3 2016
30 Jun 2016	0.19%	-0.1%	$27,088,000	23,382,000	-11,897,000	-34%	115.85%	Q2 2016
31 Mar 2016	0.28%	-0%	$41,907,000	35,279,000	-74,000	-0.21%	118.79%	Q1 2016
31 Dec 2015	0.3%	+0%	$47,484,000	35,353,000	+134,000	+0.38%	134.31%	Q4 2015
30 Sep 2015	0.33%	-0%	$47,628,000	35,219,000	-196,000	-0.55%	135.23%	Q3 2015
30 Jun 2015	0.35%	+0.03%	$56,644,000	35,415,000	+3,304,000	+10%	159.94%	Q2 2015
31 Mar 2015	0.31%	-0%	$48,609,000	32,111,000	-118,000	-0.37%	151.38%	Q1 2015
31 Dec 2014	0.26%	-0.01%	$39,341,000	32,229,000	-1,824,000	-5.4%	122.07%	Q4 2014
30 Sep 2014	0.25%	-0.08%	$37,600,000	34,053,000	-10,169,000	-23%	110.42%	Q3 2014
30 Jun 2014	0.3%	+0.07%	$46,596,000	44,222,000	+9,919,000	+29%	105.37%	Q2 2014
31 Mar 2014	0.25%	-0%	$38,078,000	34,303,000	-409,000	-1.2%	111.0%	Q1 2014
31 Dec 2013	0.24%	0%	$37,446,000	34,712,000	0		107.88%	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.